MXPA05007146A - Copolimeros en bloque de polipeptido-poli(etilenglicol) de ramificaciones multiples como vehiculos para suministro de farmacos. - Google Patents

Copolimeros en bloque de polipeptido-poli(etilenglicol) de ramificaciones multiples como vehiculos para suministro de farmacos.

Info

Publication number
MXPA05007146A
MXPA05007146A MXPA05007146A MXPA05007146A MXPA05007146A MX PA05007146 A MXPA05007146 A MX PA05007146A MX PA05007146 A MXPA05007146 A MX PA05007146A MX PA05007146 A MXPA05007146 A MX PA05007146A MX PA05007146 A MXPA05007146 A MX PA05007146A
Authority
MX
Mexico
Prior art keywords
copolymer
arm
poly
ethylene glycol
drug delivery
Prior art date
Application number
MXPA05007146A
Other languages
English (en)
Inventor
Emoto Kazunori
Original Assignee
Nektar Therapeutics Al Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al Corp filed Critical Nektar Therapeutics Al Corp
Publication of MXPA05007146A publication Critical patent/MXPA05007146A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G81/00—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers
    • C08G81/02—Macromolecular compounds obtained by interreacting polymers in the absence of monomers, e.g. block polymers at least one of the polymers being obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00—Polymer mixtures characterised by other features
    • C08L2205/05—Polymer mixtures characterised by other features containing polymer components which can react with one another

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Preparation (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Electrophonic Musical Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion proporciona un copolimero en bloque de ramificaciones multiples para utilizarse en el suministro de una variedad de agentes bioactivos. El copolimero de la invencion contiene un nucleo central a partir del cual se extienden multiples (3 o mas) ramificaciones copolimericas. Cada ramificacion copolimerica posee un segmento polipeptidico interno y un segmento polimerico hidrofilico externo. De esta forma, la estructura total del copolimero comprende una region nucleo interna que incluye el nucleo central y el segmento polipeptidico interno, mientras que la region nucleo externa es hidrofilica por naturaliza. El copolimero de ramificaciones multiples de la invencion es particularmente util para el suministro de agentes biologicamente activos que se pueden atrapar dentro de la region nucleo interna.
MXPA05007146A 2002-12-30 2003-12-24 Copolimeros en bloque de polipeptido-poli(etilenglicol) de ramificaciones multiples como vehiculos para suministro de farmacos. MXPA05007146A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43737202P 2002-12-30 2002-12-30
PCT/US2003/041332 WO2004060977A1 (en) 2002-12-30 2003-12-24 Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles

Publications (1)

Publication Number Publication Date
MXPA05007146A true MXPA05007146A (es) 2005-09-21

Family

ID=32713174

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05007146A MXPA05007146A (es) 2002-12-30 2003-12-24 Copolimeros en bloque de polipeptido-poli(etilenglicol) de ramificaciones multiples como vehiculos para suministro de farmacos.

Country Status (11)

Country Link
US (3) US7316811B2 (es)
EP (1) EP1581583B1 (es)
JP (1) JP4490291B2 (es)
KR (1) KR101045504B1 (es)
CN (1) CN100349963C (es)
AT (1) ATE461961T1 (es)
AU (1) AU2003300380B2 (es)
CA (1) CA2508015C (es)
DE (1) DE60331860D1 (es)
MX (1) MXPA05007146A (es)
WO (1) WO2004060977A1 (es)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7311926B2 (en) * 2002-12-20 2007-12-25 Battelle Memorial Institute Biocomposite materials and methods for making the same
JP4490291B2 (ja) * 2002-12-30 2010-06-23 ネクター セラピューティクス アラバマ，コーポレイション 薬物送達媒体としてのマルチアーム（ｍｕｌｔｉ−ａｒｍ）ポリペプチド−ポリ（エチレングリコール）ブロックコポリマー
EP1525890A1 (en) * 2003-10-02 2005-04-27 Complex Biosystems GmbH Protein-Proteophore complexes
EP1725262B1 (en) * 2004-03-15 2021-05-26 Nektar Therapeutics Polymer-based compositions and conjugates of hiv entry inhibitors
CN101035823B (zh) * 2004-10-08 2012-07-04 弗门尼舍有限公司 两亲星型嵌段共聚物
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
PT1842557E (pt) 2004-12-22 2013-11-07 Nitto Denko Corp Vetor de fármaco e kit de vetor de fármaco para inibição da fibrose
WO2006110776A2 (en) 2005-04-12 2006-10-19 Nektar Therapeutics Al, Corporation Polyethylene glycol cojugates of antimicrobial agents
US20060263328A1 (en) * 2005-05-19 2006-11-23 Sang Van Hydrophilic polymers with pendant functional groups and method thereof
WO2006138463A2 (en) 2005-06-17 2006-12-28 Nektar Therapeutics Al, Corporation Polymer-based compositions and conjugates of non-steroidal anti-inflammatory drugs
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
US9603941B2 (en) * 2006-01-24 2017-03-28 Minghui Chai Method of preparing dendritic drugs
EP2131814A4 (en) * 2007-02-26 2011-08-03 Wisconsin Alumni Res Found POLYMIC MICROMS FOR THE RELEASE OF ACTIVE COMPOUNDS
TWI407971B (zh) 2007-03-30 2013-09-11 Nitto Denko Corp Cancer cells and tumor-related fibroblasts
US20090099062A1 (en) * 2007-05-31 2009-04-16 Ethan Lee Pyrvinium For The Treatment of Cancer
US8394391B2 (en) * 2007-08-31 2013-03-12 University Of Utah Research Foundation Drug delivery vehicle that mimics viral properties
WO2009036368A2 (en) 2007-09-14 2009-03-19 Nitto Denko Corporation Drug carriers
US20090131589A1 (en) * 2007-10-31 2009-05-21 Carmen Scholz Controlled molecular weight amino acid polymers having functionalizable backbones and end groups and processes for preparing the same
CA2720474A1 (en) * 2008-04-04 2009-10-08 Rutgers University Nanocarrier and nanogel compositions
CA2724472A1 (en) * 2008-05-13 2009-11-19 University Of Washington Micelles for intracellular delivery of therapeutic agents
WO2009140427A2 (en) * 2008-05-13 2009-11-19 University Of Washington Diblock copolymers and polynucleotide complexes thereof for delivery into cells
MX2010012236A (es) * 2008-05-13 2011-06-20 Univ Washington Portador polimerico.
ES2404136T3 (es) 2008-05-13 2013-05-24 University Of Washington Ensamblajes micelares
WO2009140423A2 (en) * 2008-05-13 2009-11-19 University Of Washington Targeted polymer bioconjugates
US8476404B1 (en) * 2008-07-04 2013-07-02 Bhalchandra Shripad Lele Selectively functionalized polyhydric compounds
EP2331069A4 (en) 2008-08-22 2011-10-26 Univ Washington HETEROGENEOUS POLYMER MICELLES FOR INTRACELLULAR DELIVERY
US8530189B2 (en) 2008-10-16 2013-09-10 Kathleen Cogan Farinas Sustained drug delivery system
EP2349339A4 (en) * 2008-10-16 2015-01-07 Kathleen Cogan Farinas EXTENDED MEDICATION DELIVERY SYSTEM
WO2010053596A1 (en) 2008-11-06 2010-05-14 University Of Washington Bispecific intracellular delivery vehicles
WO2010053597A2 (en) * 2008-11-06 2010-05-14 University Of Washington/////////////////////-+ Micelles of hydrophilically shielded membrane-destabilizing copolymers
JP5766611B2 (ja) 2008-11-06 2015-08-19 ユニヴァーシティ オブ ワシントン マルチブロック共重合体
US9593169B2 (en) 2008-12-08 2017-03-14 University Of Washington Omega-functionalized polymers, junction-functionalized block copolymers, polymer bioconjugates, and radical chain extension polymerization
US8822610B2 (en) * 2008-12-22 2014-09-02 ATRP Solutions, Inc. Control over controlled radical polymerization processes
US8815971B2 (en) 2008-12-22 2014-08-26 ATRP Solutions, Inc. Control over controlled radical polymerization processes
US8173750B2 (en) * 2009-04-23 2012-05-08 ATRP Solutions, Inc. Star macromolecules for personal and home care
US9783628B2 (en) 2009-04-23 2017-10-10 ATRP Solutions, Inc. Dual-mechanism thickening agents for hydraulic fracturing fluids
WO2014036498A2 (en) 2012-08-30 2014-03-06 ATRP Solutions, Inc. Dual mechanism thickening agents for hydraulic fracturing fluids
WO2010123574A1 (en) 2009-04-23 2010-10-28 Atrp Solutions Inc Star macromolecules for personal and home care
US20110081398A1 (en) * 2009-10-01 2011-04-07 Tyco Healthcare Group Lp Multi-mechanism surgical compositions
US8968785B2 (en) * 2009-10-02 2015-03-03 Covidien Lp Surgical compositions
US20110081701A1 (en) * 2009-10-02 2011-04-07 Timothy Sargeant Surgical compositions
US9415113B2 (en) 2009-11-18 2016-08-16 University Of Washington Targeting monomers and polymers having targeting blocks
EP2538929A4 (en) 2010-02-25 2014-07-09 Univ Johns Hopkins PROLONGED DELIVERY OF THERAPEUTIC AGENTS TO AN OCULAR COMPARTMENT
WO2012039979A2 (en) 2010-09-10 2012-03-29 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
US9587064B2 (en) 2010-12-08 2017-03-07 ATRP Solutions, Inc. Salt-tolerant star macromolecules
WO2013096939A1 (en) 2011-12-23 2013-06-27 Sri International Selective binding compounds
US20130165628A1 (en) * 2011-12-23 2013-06-27 Sri International Double Binding Constructs
AU2013214697B2 (en) * 2012-02-03 2016-10-20 Commonwealth Scientific And Industrial Research Organisation Branched polymers
EA032552B1 (ru) * 2012-03-16 2019-06-28 Дзе Джонс Хопкинс Юниверсити Препараты с контролируемым высвобождением для доставки ингибиторов hif-1
CA2867203C (en) 2012-03-16 2016-09-20 The Johns Hopkins University Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
US9827191B2 (en) 2012-05-03 2017-11-28 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
US10688041B2 (en) 2012-05-03 2020-06-23 Kala Pharmaceuticals, Inc. Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
US11596599B2 (en) 2012-05-03 2023-03-07 The Johns Hopkins University Compositions and methods for ophthalmic and/or other applications
JP6360039B2 (ja) 2012-05-03 2018-07-18 カラ ファーマシューティカルズ インコーポレイテッド 複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
WO2013166498A1 (en) 2012-05-04 2013-11-07 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
JP2014051478A (ja) * 2012-09-10 2014-03-20 Panasonic Corp 機能性物質、生体活性用薬剤及び機能性物質の生体内への浸透方法、並びに機能性物質放散装置及び空気清浄装置
KR101986702B1 (ko) * 2012-09-10 2019-06-10 웅진코웨이 주식회사 멀티 블록 공중합체-세포투과성 펩타이드 컨쥬게이트, 이의 제조방법 및 용도
JP6700789B2 (ja) 2013-02-04 2020-05-27 パイロット ポリマー テクノロジーズ， インク． 耐塩性星形高分子、耐塩性星形高分子を含む耐塩性増粘剤、耐塩性組成物の製造方法、含水組成物を耐塩性化する方法、星形高分子の製造方法
US10568975B2 (en) 2013-02-05 2020-02-25 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
US9867885B2 (en) 2013-07-30 2018-01-16 Phaserx, Inc. Block copolymers
CA2843943A1 (en) * 2014-02-20 2014-05-28 Pankaj Modi Oral formulations of chemotherapeutic agents
US10336848B2 (en) 2014-07-03 2019-07-02 Pilot Polymer Technologies, Inc. Surfactant-compatible star macromolecules
CN104109240A (zh) * 2014-07-13 2014-10-22 成都市绿科华通科技有限公司 一种可作为药物载体的多孔聚乙二醇的制备方法
CN104530438B (zh) * 2014-12-11 2017-06-06 华南理工大学 基于胆固醇修饰的pH响应多肽聚合物及制备方法和应用
JP6640736B2 (ja) * 2014-12-12 2020-02-05 日本化薬株式会社 核酸代謝拮抗剤が結合した多分岐化合物
TWI702234B (zh) * 2015-01-16 2020-08-21 中央研究院 中心核構建體及其於組設藥物分子的用途
CA2974503A1 (en) 2015-01-21 2016-07-28 Phaserx, Inc. Methods, compositions, and systems for delivering therapeutic and diagnostic agents into cells
CA2974715C (en) 2015-01-27 2020-05-05 The Johns Hopkins University Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces
WO2016183359A1 (en) 2015-05-12 2016-11-17 Blinkbio, Inc. Silicon based drug conjugates and methods of using same
US10653784B2 (en) * 2015-10-02 2020-05-19 Purdue Research Foundation Hydrophobic highly branched carbohydrate polymers
WO2017095816A1 (en) 2015-11-30 2017-06-08 Aleo Bme, Inc. Polymeric materials for biomedical applications
AU2016374759B2 (en) * 2015-12-22 2021-04-01 Nippon Kayaku Kabushiki Kaisha Polymer conjugate of sulfoxide derivative-coordinated platinum(II) complex
CA3026651A1 (en) 2016-06-09 2017-12-14 Blinkbio, Inc. Silanol based therapeutic payloads
EP3562510A4 (en) 2016-12-30 2021-01-06 Genevant Sciences GmbH BRANCHED PEG MOLECULES AND ASSOCIATED COMPOSITIONS AND PROCEDURES
US11779653B2 (en) 2017-09-29 2023-10-10 The Regents Of The University Of California Multi-armed polyrotaxane platform for protected nucleic acid delivery
WO2020181114A1 (en) * 2019-03-06 2020-09-10 Nanoly Bioscience, Inc. Dynamic covalently linked hydrogels as stabilization network platforms
CN114040751A (zh) * 2019-04-23 2022-02-11 北卡罗来纳大学教堂山分校 针对微卫星稳定型结直肠癌通过协同性免疫原性细胞死亡促进抗肿瘤响应的槲皮素和土木香内酯的纳米共递送
CN110483785B (zh) * 2019-07-01 2020-05-19 中山大学 一种三嵌段聚合物、载药纳米胶束、纳米药物及其制备方法和应用
CN112641762A (zh) * 2021-01-05 2021-04-13 吉林大学 一种八臂聚乙二醇齐墩果酸药物载体的纳米粒子及制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0632075A3 (en) 1993-06-30 1998-02-25 Shell Internationale Researchmaatschappij B.V. Liquid star polymers having terminal hydroxyl groups
JPH09504308A (ja) 1993-07-23 1997-04-28 マサチューセッツ インスティチュート オブ テクノロジー 非直鎖状の親水性−疎水性マルチブロックコポリマーのナノ粒子およびマイクロ粒子
US5395885A (en) 1993-12-17 1995-03-07 The University Of Akron Multi-arm cationic star-polymers
US5618528A (en) 1994-02-28 1997-04-08 Sterling Winthrop Inc. Biologically compatible linear block copolymers of polyalkylene oxide and peptide units
US6686446B2 (en) 1998-03-19 2004-02-03 The Regents Of The University Of California Methods and compositions for controlled polypeptide synthesis
US6150468A (en) 1998-11-12 2000-11-21 National Starch And Chemical Investment Holding Corporation Water soluble amphiphilic heteratom star polymers and their use as emulsion stabilizers in emulsion polymerization
US6328988B1 (en) * 1999-04-23 2001-12-11 Rutgers, The State University Of New Jersey Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules
US6469132B1 (en) 1999-05-05 2002-10-22 Mcgill University Diblock copolymer and use thereof in a micellar drug delivery system
EP1063254A1 (de) 1999-06-25 2000-12-27 Technische Uni München, Klinikum rechts der Isar, Inst. für Experiment. Onkoligie und Therapieforschung Copolymere für den Transport von Nukleinsäuren in die Zelle
US6225945B1 (en) * 1999-09-22 2001-05-01 Trimble Navigation Limited GPS receiver using coarse orbital parameters for achieving a fast time to first fix
US6228945B1 (en) 1999-12-20 2001-05-08 The University Of Akron Three arm star compositions of matter having diblock arms based on polyisobutylene and methods of preparation
EP1246608A4 (en) 2000-01-05 2005-05-18 Imarx Therapeutics Inc PHARMACEUTICAL PREPARATIONS FOR THE ADMINISTRATION OF ACTIVE SUBSTANCES WITH LOW WATER SOLUBILITY
US20020041898A1 (en) 2000-01-05 2002-04-11 Unger Evan C. Novel targeted delivery systems for bioactive agents
US7261875B2 (en) 2001-12-21 2007-08-28 Board Of Regents, The University Of Texas System Dendritic poly (amino acid) carriers and methods of use
JP4490291B2 (ja) 2002-12-30 2010-06-23 ネクター セラピューティクス アラバマ，コーポレイション 薬物送達媒体としてのマルチアーム（ｍｕｌｔｉ−ａｒｍ）ポリペプチド−ポリ（エチレングリコール）ブロックコポリマー

Also Published As

Publication number Publication date
AU2003300380A1 (en) 2004-07-29
US8323632B2 (en) 2012-12-04
CN1732212A (zh) 2006-02-08
KR20050091050A (ko) 2005-09-14
WO2004060977A1 (en) 2004-07-22
EP1581583A1 (en) 2005-10-05
US20040161403A1 (en) 2004-08-19
ATE461961T1 (de) 2010-04-15
AU2003300380B2 (en) 2008-11-06
US7316811B2 (en) 2008-01-08
US20080069902A1 (en) 2008-03-20
CA2508015A1 (en) 2004-07-22
US7976834B2 (en) 2011-07-12
CA2508015C (en) 2012-04-03
US20110237747A1 (en) 2011-09-29
DE60331860D1 (en) 2010-05-06
CN100349963C (zh) 2007-11-21
JP2006512462A (ja) 2006-04-13
EP1581583B1 (en) 2010-03-24
JP4490291B2 (ja) 2010-06-23
KR101045504B1 (ko) 2011-06-30

Similar Documents

Publication Publication Date Title
MXPA05007146A (es) Copolimeros en bloque de polipeptido-poli(etilenglicol) de ramificaciones multiples como vehiculos para suministro de farmacos.
EP1820495A3 (en) Microspheres for active embolization
ATE313586T1 (de) Mehrarmige blockcopolymere und pharmazeutische zusammensetzung
WO2003044076A8 (en) Bioerodible poly(ortho esters) containing amine groups, and block copolymers containing them
CA2338605A1 (en) Pliable and moldable polymeric delivery system for bioactive agents
WO2002049535A3 (en) Medicated polymer-coated stent assembly
WO2002043785A3 (en) Intraocular implants for preventing transplant rejection in the eye
EP2671507A3 (en) Pharma-informatics system
CA2449244A1 (en) Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug
WO2006101815A3 (en) Pharmaceutical compositions comprising polyoxaester and active agents for use with osmotic delivery systems
CA2355657A1 (en) Biodegradable ph/thermosensitive hydrogels for sustained delivery of biologically active agents
EP2258415A3 (en) Medical devices containing rapamycin analogs
WO2001060335A3 (en) Delivery systems using preformed biodegradable polymer compositions and methods
WO2001049258A3 (en) Methods and compositions for improved delivery devices
ATE374049T1 (de) System zur abgabe von wirkstoffen mit einem hydrophoben cellulose-derivat
MXPA03009007A (es) Suspension coloidal de nanoparticulas a base de un copolimero anfifilico.
EP1690530A3 (en) Sustained release pharmaceutical composition free of food effect and a method for alleviating food effect in drug release
CA2304976A1 (en) Delivery of poly(ethylene glycol)-conjugated molecules from degradable hydrogels
IL156887A0 (en) Implants with fk506
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
YU89683A (en) Method of preparing a pharmaceutically or veterinary acceptable amphipathic non-crosslinked linear, branched or graft block-copolymer
EP1772122A3 (en) Expandable medical device for delivery of beneficial agent
CA2235919A1 (en) Non-polymeric sustained release delivery system
HK1069126A1 (en) Drug microparticles
EP1569664A4 (en) BIOERODABLE POLY (ORTHO ESTERS) PREPARED FROM DI (CETENE ACETALS) BASED ON DIOXANE AND COPOLYMER SEQUENCES CONTAINING THE SAME

Legal Events

Date Code Title Description
FG Grant or registration
GB Transfer or rights
HH Correction or change in general